MiniDock MTB Listed

 

In July 2025, Pluslife’s MiniDock MTB Test was officially listed as a Category-2 product under the ERPD, making it eligible for procurement under Global Fund-supported programs. This listing reflects a milestone in the product’s recognition within international public health procurement systems.

More >

Partnership with Gates Foundation

 

Pluslife's TB diagnostic solutions are advancing toward WHO prequalification, with funding support from Gates Foundation. This collaboration follows a July agreement with them a precision diagnostic project for STIs.

More >

Collaboration with FIND 

 

Developing the HPV project with FIND for the benefit of women in less developed countries. Pluslife HPV 16/18/45 product exhibits excellent clinical performance.

More >